NEW Summary Report Guidance Document Released by Health Canada

Back in December 23, 2021, Health Canada formally added the requirements of Summary Reports into the Canadian Medical Device Regulations; however, there was never a guidance document or further explanation as to what and how the Summary Reports should be structured. 5 years later, on April 9, 2026 they finally released the Guidance Document.

First, if you are a Class I medical device manufacturer, you can stop reading here. The summary report is not applicable to you. Summary report requirements are only for manufacturers of Class II, III and IV device manufacturers at a specified interval. This is also a requirement for private label manufacturers. Devices for urgent public health need (UPHN) are exempt.

--> Class II (to be completed once every two years)

--> Class III and IV (to be completed every year)

Just because the summary report was a requirement that was initiated back in 2021; the content of the summary report should include a cumulative summary from the date of first licensing, authorization or sale in Canada, and conclusions that are specific to the reporting period. If the device has been in the market for awhile, it is important to identify any new emerging trends. In addition, information specific to the Canadian context is important, however, other jurisdiction where the device is sold under different names should also be included in the report. The conclusion of the summary report is also important. Identifying any changes to benefit or risk will trigger a notification to Health Canada within 72 hours of such awareness. Even if it did not, then a risk benefit summary should be captured.

At A. Quality | Regulatory Consulting Firm, we can provide templates and support to help you prepare compliant and effective summary reports. Contact us today to receive your free template and learn how we can support your regulatory and quality compliance needs.